The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects

The aim of this study was to determine the changes of short chain fatty acids (SCFAs) in faeces of inflammatory bowel disease (IBD) patients compared to healthy subjects. SCFAs such as pyruvic, lactic, formic, acetic, propionic, isobutyric and butyric acids were analyzed by using high performance liquid chromatography (HPLC). This study showed that the level of acetic, 162.0 µmol/g wet faeces, butyric, 86.9 µmol/g wet faeces, and propionic acids, 65.6 µmol/g wet faeces, decreased remarkably in IBD faecal samples when compared with that of healthy individuals, 209.7, 176.0, and 93.3 µmol/g wet faeces respectively. On the contrary, lactic and pyruvic acids showed higher levels in faecal samples of IBD than in healthy subjects. In the context of butyric acid level, this study also found that the molar ratio of butyric acid was higher than propionic acid in both faecal samples. This might be due to the high intake of starch from rice among Malaysian population. It was concluded that the level of SCFAs differ remarkably between faecal samples in healthy subjects and that in IBD patients providing evidence that SCFAs more likely play an important role in the pathogenesis of IBD.

[1]  B. Lembcke,et al.  Simple and rapid method for determination of short-chain fatty acids in biological materials by high-performance liquid chromatography with ultraviolet detection. , 1992, Journal of chromatography.

[2]  C. Cherbut,et al.  Lactate is mainly fermented to butyrate by human intestinal microfloras but inter‐individual variation is evident , 2005, Journal of applied microbiology.

[3]  J. Cummings,et al.  The large intestine in nutrition and disease. , 1997 .

[4]  J. Barnard,et al.  Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[5]  P. Mortensen,et al.  Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. , 1987, Scandinavian journal of gastroenterology.

[6]  P. Conway,et al.  Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amylomaize) starch granules , 2002, Journal of applied microbiology.

[7]  Ian C. Talbot,et al.  The Large Intestine: Physiology, Pathophysiology and Disease , 1993 .

[8]  W. Scheppach,et al.  Role of short-chain fatty acids in the prevention of colorectal cancer. , 1995, European journal of cancer.

[9]  Cleverson Fernando Garcia,et al.  Comparison of GC and HPLC for the quantification of organic acids in coffee. , 2002, Phytochemical analysis : PCA.

[10]  G. Corazza,et al.  Oral butyrate for mildly to moderately active Crohn's disease , 2005, Alimentary pharmacology & therapeutics.

[11]  C. Kelly Large intestine. , 2010, Current opinion in gastroenterology.

[12]  J. Cummings,et al.  Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. , 1990, The American journal of gastroenterology.

[13]  M. Floch,et al.  Probiotics and functional foods in gastrointestinal disorders , 2001, Current gastroenterology reports.

[14]  I. Hwang,et al.  Fermentation of rice using amylolytic Bifidobacterium , 1999 .

[15]  I. Björck,et al.  Combinations of indigestible carbohydrates affect short-chain fatty acid formation in the hindgut of rats. , 2002, The Journal of nutrition.

[16]  T. Morita,et al.  Resistant proteins alter cecal short-chain fatty acid profiles in rats fed high amylose cornstarch. , 1998, The Journal of nutrition.

[17]  I. Björck,et al.  Increasing Fecal Butyrate in Ulcerative Colitis Patients by Diet: Controlled Pilot Study , 2003, Inflammatory bowel diseases.

[18]  G. Gibson,et al.  In vitro fermentation of sugar beet arabinan and arabino‐oligosaccharides by the human gut microflora , 2006, Journal of applied microbiology.

[19]  P. Vernia,et al.  Organic anions and the diarrhea of inflammatory bowel disease , 1988, Digestive Diseases and Sciences.

[20]  M. Chapman,et al.  In vivo colonic butyrate metabolism and colonic permeability in extensive ulcerative colitis. , 1998, Gastroenterology.

[21]  M. Wolin,et al.  Characterization of Carbohydrate Fermentation in Feces of Formula-Fed and Breast-Fed Infants , 1990, Pediatric Research.

[22]  P. Rutgeerts,et al.  In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. , 1998, Gastroenterology.

[23]  R. D. de Souza,et al.  Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.

[24]  I. Björck,et al.  Dietary supplementation with β-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects , 2008, European Journal of Clinical Nutrition.

[25]  C. Lifschitz,et al.  Preparation of fecal samples for assay of volatile fatty acids by gas-liquid chromatography and high-performance liquid chromatography. , 1989, Clinical chemistry.

[26]  A. Prader,et al.  ACQUIRED MILK INTOLERANCE IN THE ADULT CAUSED BY LACTOSE MALABSORPTION DUE TO A SELECTIVE DEFICIENCY OF INTESTINAL LACTASE ACTIVITY. , 1965, The American journal of medicine.

[27]  C. M. Wood,et al.  Absorption of short-chain fatty acids by the colon. , 1980, Gastroenterology.

[28]  G. Mills,et al.  Headspace solid-phase microextraction with 1-pyrenyldiazomethane in-fibre derivatisation for analysis of faecal short-chain fatty acids. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[29]  Q. Mckellar,et al.  Determination of short-chain fatty acids in equine caecal liquor by ion exchange high performance liquid chromatography after solid phase extraction. , 1991, Biomedical chromatography : BMC.

[30]  H. Ogata,et al.  Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. , 2008, International journal of medical microbiology : IJMM.

[31]  H. Englyst,et al.  Prebiotic digestion and fermentation. , 2001, The American journal of clinical nutrition.

[32]  G. Porto,et al.  World J Gastroenterol , 2010 .

[33]  G PLACITELLI,et al.  [Ulcerative colitis]. , 1958, La Riforma medica.

[34]  T. Wolever,et al.  Interaction between colonic acetate and propionate in humans. , 1991, The American journal of clinical nutrition.

[35]  D. Brocks,et al.  Metabolic acidosis: separation methods and biological relevance of organic acids and lactic acid enantiomers. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[36]  W. Roediger Utilization of nutrients by isolated epithelial cells of the rat colon. , 1982, Gastroenterology.

[37]  C. FordAlexander,et al.  ULCERATIVE colitis. , 1997, Journal of the American Medical Association.

[38]  W. Scheppach,et al.  Fecal short-chain fatty acid (SCFA) analysis by capillary gas-liquid chromatography. , 1987, The American journal of clinical nutrition.

[39]  J. Weststrate,et al.  Safety evaluation of phytosterol esters. Part 5. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[40]  M. Nyman,et al.  Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. , 2006, Biomedical chromatography : BMC.

[41]  J. Hyams,et al.  Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. , 1996, Journal of pediatric gastroenterology and nutrition.

[42]  S. Tedelind,et al.  Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. , 2007, World journal of gastroenterology.

[43]  J. Cummings Short‐chain fatty acid enemas in the treatment of distal ulcerative colitis , 1997, European journal of gastroenterology & hepatology.

[44]  K. Richter,et al.  Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells. , 2007, The British journal of nutrition.

[45]  H. Ogata,et al.  The emergence of inflammatory bowel disease in the Asian Pacific region , 2005, Current opinion in gastroenterology.

[46]  H. Flint,et al.  The microbiology of butyrate formation in the human colon. , 2002, FEMS microbiology letters.

[47]  A. Dignass,et al.  Epithelial restitution and wound healing in inflammatory bowel disease. , 2008, World journal of gastroenterology.

[48]  T. Sakata,et al.  Galactosylsucrose and xylosylfructoside alter digestive tract size and concentrations of cecal organic acids in rats fed diets containing cholesterol and cholic acid. , 1994, The Journal of nutrition.

[49]  T. Sakata Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors , 1987, British Journal of Nutrition.

[50]  C. Barbas,et al.  Capillary electrophoresis for short chain organic acids in faeces Reference values in a Mediterranean elderly population. , 2008, Journal of pharmaceutical and biomedical analysis.

[51]  G. Cresci,et al.  GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. , 2009, Cancer research.